Agile replaces CEO to gain 'more commercial focus'
This article was originally published in Scrip
Executive Summary
Agile Therapeutics, which raised $45 million in a series B financing earlier this year, is replacing its CEO Dr Thomas Rossi with its chairman Al Altomari effective immediately.